NEW YORK, Oct 12 – LaunchCyte, a bioinformatics incubator based in Pittsburgh, said Thursday it has raised $2 million in financing and has announced the appointments of senior science and finance executives.

“In five months we've gone from zero to $2 million and from nobody to a staff of 12,” Tom Petzinger, LaunchCyte’s chairman and chief executive, said in a statement. “Pulling this off is a testament to the opportunity we have in Pittsburgh and to the team we've recruited to capitalize on it.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.